Vintafolide: a novel targeted agent for epithelial ovarian cancer.
about
Microtubule inhibitor, SP-6-27 inhibits angiogenesis and induces apoptosis in ovarian cancer cells.Pemetrexed for ovarian cancer: a systematic review of the published literature and a consecutive series of patients treated in a nonclinical trial setting.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
P2860
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@en
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@nl
type
label
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@en
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@nl
prefLabel
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@en
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@nl
P2860
P356
P1433
P1476
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
@en
P2093
Robert L Coleman
Whitney S Graybill
P2860
P304
P356
10.2217/FON.14.8
P407
P577
2014-03-01T00:00:00Z